Opinion: Let’s Remember That This Brought Out the Best in Us
May 15th 2020Lili Brillstein, CEO of BCollaborative and member of the Managed Healthcare Executive® editorial advisory board discusses how the global shut-down and stay-at-home orders due to the COVID-19 pandemic have benefitted us in many ways.
Read More
Videoconferencing Eases Anxiety, Distress of the ‘Distance’ Caregivers of Cancer Patients
May 13th 2020Videoconferencing reduced anxiety and stress among “distance caregivers,” according to the results of randomized trial scheduled to be presented at the annual meeting of the American Society of Clinical Oncology.
Read More
ACA Medicaid Expansion Shows Cancer Mortality Benefit, Especially Among Hispanics
May 13th 2020Medicaid expansion under the Affordable Care Act resulted in a decrease in cancer mortality rates that translated into 785 fewer cancer deaths in 2017 expansion states, according to results of a study scheduled to be presented at annual meeting of American Society of Clinical Oncology (ASCO), which is now scheduled to be held virtually May 29-31 instead of in Chicago.
Read More
Staying Safe and Cyber-Secure Through Telehealth
May 7th 2020As social distancing has become the new norm due to COVID-19, the new normal for healthcare has also seen a rise of telehealth services. However, there are security risks involved for patients’ personal data and companies’ private information.
Read More
Farxiga, Developed for Diabetes, Gets FDA Nod for Heart Failure
May 7th 2020The FDA recently approved AstraZeneca’s Farxiga (dapagliflozin) for the treatment of heart failure with reduced ejection fraction (HFrEF) in adults with and without type 2 diabetes, marking the first time a drug in a class developed for diabetes was approved for heart failure even if diabetes is not present.
Read More